001     268719
005     20240808164551.0
024 7 _ |a pmc:PMC11010029
|2 pmc
024 7 _ |a 10.1161/JAHA.123.033439
|2 doi
024 7 _ |a pmid:38456438
|2 pmid
024 7 _ |a altmetric:161078992
|2 altmetric
037 _ _ |a DZNE-2024-00298
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a von Rennenberg, Regina
|0 P:(DE-2719)9001452
|b 0
|e First author
245 _ _ |a High-Sensitivity Cardiac Troponin T and Cognitive Function Over 12 Months After Stroke-Results of the DEMDAS Study.
260 _ _ |a New York, NY
|c 2024
|b Association
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1711368665_22710
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Subclinical myocardial injury in form of hs-cTn (high-sensitivity cardiac troponin) levels has been associated with cognitive impairment and imaging markers of cerebral small vessel disease (SVD) in population-based and cardiovascular cohorts. Whether hs-cTn is associated with domain-specific cognitive decline and SVD burden in patients with stroke remains unknown.We analyzed patients with acute stroke without premorbid dementia from the prospective multicenter DEMDAS (DZNE [German Center for Neurodegenerative Disease]-Mechanisms of Dementia after Stroke) study. Patients underwent neuropsychological testing 6 and 12 months after the index event. Test results were classified into 5 cognitive domains (language, memory, executive function, attention, and visuospatial function). SVD markers (lacunes, cerebral microbleeds, white matter hyperintensities, and enlarged perivascular spaces) were assessed on cranial magnetic resonance imaging to constitute a global SVD score. We examined the association between hs-cTnT (hs-cTn T levels) and cognitive domains as well as the global SVD score and individual SVD markers, respectively. Measurement of cognitive and SVD-marker analyses were performed in 385 and 466 patients with available hs-cTnT levels, respectively. In analyses adjusted for demographic characteristics, cardiovascular risk factors, and cognitive status at baseline, higher hs-cTnT was negatively associated with the cognitive domains 'attention' up to 12 months of follow-up (beta-coefficient, -0.273 [95% CI, -0.436 to -0.109]) and 'executive function' after 12 months. Higher hs-cTnT was associated with the global SVD score (adjusted odds ratio, 1.95 [95% CI, 1.27-3.00]) and the white matter hyperintensities and lacune subscores.In patients with stroke, hs-cTnT is associated with a higher burden of SVD markers and cognitive function in domains linked to vascular cognitive impairment.URL: https://www.clinicaltrials.gov; Unique identifier: NCT01334749.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a acute stroke
|2 Other
650 _ 7 |a cardiac troponin
|2 Other
650 _ 7 |a cognitive impairment
|2 Other
650 _ 7 |a heart and brain axis
|2 Other
650 _ 7 |a Troponin T
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Troponin T
|2 MeSH
650 _ 2 |a Prospective Studies
|2 MeSH
650 _ 2 |a Neurodegenerative Diseases: complications
|2 MeSH
650 _ 2 |a Stroke: diagnosis
|2 MeSH
650 _ 2 |a Stroke: epidemiology
|2 MeSH
650 _ 2 |a Stroke: complications
|2 MeSH
650 _ 2 |a Cognition
|2 MeSH
650 _ 2 |a Cognitive Dysfunction: diagnosis
|2 MeSH
650 _ 2 |a Cognitive Dysfunction: epidemiology
|2 MeSH
650 _ 2 |a Cognitive Dysfunction: etiology
|2 MeSH
650 _ 2 |a Cerebral Small Vessel Diseases: epidemiology
|2 MeSH
650 _ 2 |a Cerebral Small Vessel Diseases: complications
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging
|2 MeSH
650 _ 2 |a Dementia
|2 MeSH
700 1 _ |a Nolte, Christian
|0 P:(DE-2719)9000234
|b 1
700 1 _ |a Liman, Thomas G
|0 P:(DE-2719)9000189
|b 2
700 1 _ |a Hellwig, Simon
|0 0000-0002-6925-4768
|b 3
700 1 _ |a Riegler, Christoph
|0 0000-0002-2478-3500
|b 4
700 1 _ |a Scheitz, Jan F
|0 P:(DE-2719)9001514
|b 5
700 1 _ |a Georgakis, Marios K
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Fang, Rong
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Bode, Felix
|0 P:(DE-2719)2811949
|b 8
|u dzne
700 1 _ |a Petzold, Gabor C
|0 P:(DE-2719)2810273
|b 9
|u dzne
700 1 _ |a Hermann, Peter
|0 P:(DE-2719)2812183
|b 10
700 1 _ |a Zerr, Inga
|0 P:(DE-2719)2000058
|b 11
700 1 _ |a Görtler, Michael
|0 P:(DE-2719)2811292
|b 12
700 1 _ |a Bernkopf, Kathleen
|b 13
700 1 _ |a Wunderlich, Silke
|b 14
700 1 _ |a Dichgans, Martin
|0 P:(DE-2719)2000030
|b 15
700 1 _ |a Endres, Matthias
|0 P:(DE-2719)2811033
|b 16
|e Last author
700 1 _ |a , DEMDAS investigators
|b 17
|e Collaboration Author
700 1 _ |a Endres, Matthias
|b 18
|e Contributor
700 1 _ |a Liman, Thomas G
|b 19
|e Contributor
700 1 _ |a Kerti, Lucia
|b 20
|e Contributor
700 1 _ |a Nolte, Christian H
|b 21
|e Contributor
700 1 _ |a Wittenberg, Tatjana
|b 22
|e Contributor
700 1 _ |a Scheitz, Jan F
|b 23
|e Contributor
700 1 _ |a Prüß, Harald
|b 24
|e Contributor
700 1 _ |a Sperber, Pia Sophie
|b 25
|e Contributor
700 1 _ |a Nave, Alexander H
|b 26
|e Contributor
700 1 _ |a Ibaroule, Anna Kufner
|b 27
|e Contributor
700 1 _ |a Petzold, Gabor
|b 28
|e Contributor
700 1 _ |a Bode, Felix
|b 29
|e Contributor
700 1 _ |a Stösser, Sebastian
|b 30
|e Contributor
700 1 _ |a Meissner, Julius
|b 31
|e Contributor
700 1 _ |a Ebrahimi, Taraneh
|b 32
|e Contributor
700 1 _ |a Nordsiek, Julia
|b 33
|e Contributor
700 1 _ |a Beckonert, Niklas
|b 34
|e Contributor
700 1 _ |a Kindler, Christine
|b 35
|e Contributor
700 1 _ |a Zerr, Inga
|b 36
|e Contributor
700 1 _ |a Hermann, Peter
|b 37
|e Contributor
700 1 _ |a Schmitz, Matthias
|b 38
|e Contributor
700 1 _ |a Goebel, Stefan
|b 39
|e Contributor
700 1 _ |a Bunck, Timothy
|b 40
|e Contributor
700 1 _ |a Schütte-Schmidt, Julia
|b 41
|e Contributor
700 1 _ |a Nuhn, Sabine
|b 42
|e Contributor
700 1 _ |a Volpers, Corinna
|b 43
|e Contributor
700 1 _ |a Dechent, Peter
|b 44
|e Contributor
700 1 _ |a Bähr, Mathias
|b 45
|e Contributor
700 1 _ |a Görtler, Michael
|b 46
|e Contributor
700 1 _ |a Glanz, Wenzel
|b 47
|e Contributor
700 1 _ |a Perosa, Valentina
|b 48
|e Contributor
700 1 _ |a Dichgans, Martin
|b 49
|e Contributor
700 1 _ |a Wollenweber, Frank
|b 50
|e Contributor
700 1 _ |a Fang, Rong
|b 51
|e Contributor
700 1 _ |a Janowitz, Daniel
|b 52
|e Contributor
700 1 _ |a Waegemann, Karin
|b 53
|e Contributor
700 1 _ |a Tiedt, Steffen
|b 54
|e Contributor
700 1 _ |a Wunderlich, Silke
|b 55
|e Contributor
700 1 _ |a Ikenberg, Benno
|b 56
|e Contributor
700 1 _ |a Bernkopf, Kathleen
|b 57
|e Contributor
700 1 _ |a Huber, Christiane
|b 58
|e Contributor
700 1 _ |a Poppert, Holger
|b 59
|e Contributor
700 1 _ |a Düring, Marco
|b 60
|e Contributor
700 1 _ |a Araque Caballero, Miguel Ángel
|b 61
|e Contributor
700 1 _ |a Gieserich, Benno
|b 62
|e Contributor
700 1 _ |a Dewenter, Anna
|b 63
|e Contributor
700 1 _ |a Dobisch, Laura
|b 64
|e Contributor
700 1 _ |a Neumann, Katja
|b 65
|e Contributor
700 1 _ |a Speck, Oliver
|b 66
|e Contributor
700 1 _ |a Spottke, Annika
|b 67
|e Contributor
700 1 _ |a Stöcker, Tony
|b 68
|e Contributor
700 1 _ |a Bartenstein, Peter
|b 69
|e Contributor
700 1 _ |a Wagner, Michael
|b 70
|e Contributor
773 _ _ |a 10.1161/JAHA.123.033439
|g Vol. 13, no. 6, p. e033439
|0 PERI:(DE-600)2653953-6
|n 6
|p e033439
|t Journal of the American Heart Association
|v 13
|y 2024
|x 2047-9980
856 4 _ |u https://pub.dzne.de/record/268719/files/DZNE-2024-00298%20SUP.pdf
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/268719/files/DZNE-2024-00298.pdf
856 4 _ |x pdfa
|u https://pub.dzne.de/record/268719/files/DZNE-2024-00298%20SUP.pdf?subformat=pdfa
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/268719/files/DZNE-2024-00298.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:268719
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9001452
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9000234
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)9000189
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-HGF)0
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 8
|6 P:(DE-2719)2811949
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)2810273
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)2812183
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 11
|6 P:(DE-2719)2000058
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 12
|6 P:(DE-2719)2811292
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 15
|6 P:(DE-2719)2000030
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 16
|6 P:(DE-2719)2811033
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-29
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J AM HEART ASSOC : 2022
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2022-11-30T16:55:33Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2022-11-30T16:55:33Z
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-29
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2022-11-30T16:55:33Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-08-29
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J AM HEART ASSOC : 2022
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-29
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-08-29
920 1 _ |0 I:(DE-2719)1811005
|k AG Endres
|l Interdisciplinary Dementia Research
|x 0
920 1 _ |0 I:(DE-2719)5000022
|k AG Dichgans
|l Vascular Cognitive Impairment & Post-Stroke Dementia
|x 1
920 1 _ |0 I:(DE-2719)1013020
|k AG Petzold ; AG Petzold
|l Vascular Neurology
|x 2
920 1 _ |0 I:(DE-2719)1440011-1
|k AG Zerr
|l Translational Studies and Biomarker
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1811005
980 _ _ |a I:(DE-2719)5000022
980 _ _ |a I:(DE-2719)1013020
980 _ _ |a I:(DE-2719)1440011-1
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21